Marshall Wace’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.7M Buy
91,200
+90,500
+12,929% +$43.4M 0.04% 410
2026
Q1
$344K Buy
+700
New +$380K ﹤0.01% 2603
2025
Q3
Sell
-75,000
Closed -$30.4M 3405
2025
Q2
$30.4M Buy
+75,000
New +$31.4M 0.03% 435
2024
Q3
Sell
-40,000
Closed -$22.1M 2956
2024
Q2
$22.1M Buy
+40,000
New +$22.9M 0.03% 467
2021
Q4
Sell
-12,100
Closed -$6.91M 4276
2021
Q3
$6.91M Buy
12,100
+11,900
+5,950% +$6.53M 0.03% 770
2021
Q2
$101K Hold
200
﹤0.01% 2535
2021
Q1
$91K Buy
+200
New +$95.5K ﹤0.01% 2362

Other funds holding TMO

Marshall Wace's TMO Position: Q2 2026 in Review

Marshall Wace reduced its Thermo Fisher Scientific (TMO) stake by 99% in Q2 2026, selling an estimated $227M and leaving 4,321 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1818.

Marshall Wace first reported a position in TMO in Q1 2014 and has held it in 35 quarters since. The position peaked at $696M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Marshall Wace held 4,321 shares of Thermo Fisher Scientific worth $2.17M as of Q2 2026.
  • Marshall Wace sold 472,929 Thermo Fisher Scientific shares in Q2 2026, an estimated $227M.
  • Thermo Fisher Scientific made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1818 holding.
  • Marshall Wace first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 35 quarters since.
  • Marshall Wace's Thermo Fisher Scientific position peaked at $696M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.